Navigation Links
ACORN Expands Presence in EDC Market with Commercialization of Guardian EDC(TM)
Date:5/14/2008

MEMPHIS, Tenn., May 14 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN), an oncology-focused CRO and research network, announced today that it is making its Electronic Data Capture (EDC) system, Guardian EDC(TM), commercially available. This proprietary system will be available for all studies, including those outside of oncology. Previously, Guardian EDC (TM) has only been available to studies within the ACORN clinical trial portfolio.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

"Since its deployment, the web-based Guardian EDC(TM) has been used in multiple industry-sponsored trials, investigator initiated trials, and large observational trials," according to Ed Stepanski, Chief Operating Officer. "We believe Guardian provides an extremely secure, functional, and economically attractive EDC alternative to pharmaceutical sponsors and CROs in both oncology and other medical specialties."

Guardian EDC(TM) satisfies and or surpasses all applicable FDA regulations, including 21 CFR Part 11. Among its more significant features are automatic randomization; full on-screen audit trail capability, providing user identification, date, time and reason for edit; auto-generating reports; and electronic principal investigator signatures. For convenience, Guardian EDC(TM) provides extensive study amendment capabilities.

"In the development process we analyzed the strengths and weaknesses of all the EDCs our network worked with over the last 5 years," according to Bridget Rose, Guardian EDC(TM) Project Leader. "We then designed a system which meets the demanding needs of oncology clinical research and are quite pleased with the end product. Guardian has proven to be a critical component of our successful clinical trial program."

Guardian EDC(TM) enhances study efficiencies for both industry sponsors and participating practices. It places study information at the fingertips of users in one centralized location with the ability to drill down to minute detail. User-friendly, intuitive navigation virtually eliminates any learning curve and has been responsible for high user acceptance ratings.

"Having experience with multiple systems, we have found Guardian to be the most straightforward, user friendly EDC our practice has used," according to Lynn Kaplan, research coordinator with Tri-County Hematology & Oncology Associates in Canton, Ohio. "It's obvious, careful review and planning went into the development of this EDC by people doing quality clinical research."

Davis Templeton, CMO, is leading commercialization efforts for Guardian EDC(TM) and can be reached at dtempleton@sosacorn.com or 720-304-6536. Guardian EDC(TM) will also be demonstrated at the upcoming DIA annual meeting in Boston, June 22-26.

Accelerated Community Oncology Research Network, Inc. (ACORN)

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Rohm and Haas Expands in India
4. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
5. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
6. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
7. Specialty Blades, Inc. Expands Management Team With New VP Engineering
8. CRH Medical expands Las Vegas operations
9. US Med-Equip Expands Corporate Support Center
10. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
11. Bipartisan Bill Expands Health Care Access for Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: